Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C and HIV Coinfection => Topic started by: Hep Editors on July 31, 2017, 10:08:37 am

Title: New Hep C Combo Cures Most People Coinfected With HIV
Post by: Hep Editors on July 31, 2017, 10:08:37 am
AbbVie’s new Maviret (glecaprevir/pibrentasvir) coformulation taken for 8 or 12 weeks led to a sustained response in almost all HIV-positive people with hepatitis C in the EXPEDITION-2 study, according to a presentation at the 9th International AIDS Society Conference on HIV Science (IAS 2017) taking place this week in Paris.

Maviret demonstrated an overall cure rate of 98 percent, and all study participants without liver cirrhosis were cured with an eight-week course of therapy, reported Karine Lacombe, MD, of Saint-Antoine Hospital in Paris.

For more...